“What about ResApp-DX?”
A casual reply: Yeah, we are making money from Alodokter, Medgate and other parties…
This company’s core product is ResApp-Dx,and always will be. I’ve used it in Telehealth setting for my kid and it was definitely a very, very helpful.
The value lies in ResApp-DX. Of course Covid screening app is great to have, but there lies the risk of taking that product to market-not ResApp-DX.
Not a word about ResApp-DX until asked! Appalling.
NO
Ann: Investor Webinar, page-28
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
